Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators
- PMID: 20733021
- DOI: 10.1136/bjo.2009.168062
Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators
Abstract
Background: The survival of retinoblastoma in less-developed countries (LDCs) and the impact of socioeconomic variables on survival are not widely available in the literature.
Methods: A systematic review of publications from LDCs was performed. Articles were from multiple databases and written in seven languages. Results were correlated with socioeconomic indicators. Lower-income countries (LICs) and middle-income countries (MICs) were included in our analyses.
Results: An analysis of 164 publications including 14,800 patients from 48 LDCs was performed. Twenty-six per cent of the papers were written in languages other than English. Estimated survival in LICs was 40% (range, 23-70%); in lower MICs, 77% (range, 60-92%) and in upper MICs, 79% (range, 54-93%; p = 0.001).Significant differences were also found in the occurrence of metastasis: in LICs, 32% (range, 12-45); in lower MICs, 12% (range, 3-31) and in upper MICs, 9.5% (range, 3-24; p = 0.04). On multivariate analysis, physician density and human development index were significantly associated with survival and metastasis. Maternal mortality rate and per capita health expenditure were significantly associated with treatment refusal.
Conclusions: Important information from LDCs is not always available in English or in major databases. Indicators of socioeconomic development and maternal and infant health were related with outcome.
Comment in
-
Challenging the global retinoblastoma survival disparity through a collaborative research effort.Br J Ophthalmol. 2010 Nov;94(11):1415-6. doi: 10.1136/bjo.2009.174136. Epub 2010 Aug 1. Br J Ophthalmol. 2010. PMID: 20679076 No abstract available.
Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Second Malignant Neoplasms in Long-term Retinoblastoma Survivors: Retrospective Cohort Study of 491 Patients in Turkey.J Pediatr Hematol Oncol. 2025 Jul 1;47(5):e161-e167. doi: 10.1097/MPH.0000000000003039. Epub 2025 Apr 21. J Pediatr Hematol Oncol. 2025. PMID: 40262045
Cited by
-
Subsequent Malignant Neoplasms in Retinoblastoma Survivors.Cancers (Basel). 2021 Mar 10;13(6):1200. doi: 10.3390/cancers13061200. Cancers (Basel). 2021. PMID: 33801943 Free PMC article. Review.
-
Effect of miR-215 on the Expression of Tumor Suppressor Gene Rb1 in Retinoblastoma Cell Lines.Iran J Public Health. 2020 Jul;49(7):1298-1306. doi: 10.18502/ijph.v49i7.3583. Iran J Public Health. 2020. PMID: 33083296 Free PMC article.
-
Anemia and Bone Marrow Suppression After Intra-Arterial Chemotherapy in Children With Retinoblastoma: A Retrospective Analysis.Front Oncol. 2022 Jul 25;12:848877. doi: 10.3389/fonc.2022.848877. eCollection 2022. Front Oncol. 2022. PMID: 35957866 Free PMC article.
-
Krüppel-like transcription factor 16 transcriptional up-regulation of cellular retinoic acid-binding proteins-2 promotes the invasion and migration and inhibits apoptosis of retinoblastoma cells by regulating integrin-β1/focal adhesion kinase /extracellular signal-regulated kinase pathway.Bioengineered. 2022 Feb;13(2):3694-3706. doi: 10.1080/21655979.2021.2024977. Bioengineered. 2022. PMID: 35671035 Free PMC article.
-
Global Retinoblastoma Presentation and Analysis by National Income Level.JAMA Oncol. 2020 May 1;6(5):685-695. doi: 10.1001/jamaoncol.2019.6716. JAMA Oncol. 2020. PMID: 32105305 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources